718 /SQUILL PDR FOR HERBAL MEDICINES
drug; lidocaine for ventricular extrasystole; for pronounced
bradycardia, atropine or orciprenaline. The prophylactic use
of a pacemaker is recommended. Hemoperfusion for elimi-
nating the glycosides or the administration of cholestyramine
for interrupting the enterohepatic circulation are possible.
DOSAGE
Mode of Administration: Comminuted drug and other galenic
preparations for internal use.
Preparation: Stabilized powder is standardized according to
content, there are no more exact specifications in the
literature, standardization according to DABIO.
Squill Extract — Evaporated extract l :4; drug: diluted spirit
of wine (EB6)
Acetum Scillae — drug: spirit of wine l:l (EB6)
Oxymel Scillae — 5 parts Acetum Scillae: 10 parts purified
honey evaporated in a water bath to 10 parts
Daily Dosage: Single dose: 60 to 200 mg; Daily dose: 180 to
200 mg; Average daily dosage: 0.1 to 0.5 gm of standardized
sea onion powder.
Squill Extract: 1.0 gm; Liquid extract: 0.03 to 2.0 ml;
Tincture: 0.3 to 2.0 ml; Acetum Scillae: 1.0 gm; Acetic acid
maceration: 0.6 to 2.0 ml
Oxymel Scillae: 2.5 gm
Storage: Squill should be protected from light and moisture
at temperatures below 25 °C.
LITERATURE
Brisse B, Anwendung pflanzlicher Wirkstoffe bei kardialen
Erkrankungen. In: ZPT 10(4): 107. 1989.
Eichstadt H, Hansen G, Danne O, Koch HP, Minge C, Richter
W, Schroder R, Die positiv inotrope Wirkung eines Scilla-
Extraktes nach Einmal-Applikation. In: ZPT 12(2):46. 1991.
Garcia-Casado P et al., (1977) Pharm Acta Helv 52:218.
Hakim FS, Evans FJ, (1976) Pharm Acta Helv 52:117.
Kamano Y, Satoh N, Nakayoshi H, Pettit GR, Smith CR,
Rhinovirus inhibition by bufadienolides. In: Chem Pharm Bull
36:326-332. 1988.
Karawya MS et al., (1973) Planta Med 23:213.
Kopp B, Krenn L, Jurenitsch J, Bufadienolide in Meerzwiebeln.
In: DAZ '130(40):2175. 1990.
Krenn L, Ferth R, Robien W, Kopp B, Bufadienolide aus
Urginea-maritima-sensu-strictu. In: PM 57:560. 1991.
Krenn L, Kopp B, 9-Hydroxyscilliphaeosid, a new bufadienolide
from Urginea maritima. In: JNP 59(6):612-613. 1996.
Loew D, Phytotherapie bei Herzinsuffizienz. In: ZPT 18(2):92-
Loew DA, Loew AD, Pharmakokinetik von herzglykosidhaltigen
Pflanzenextrakten. In: ZPT 15(4): 197-202. 1994.
Majinda RRT et al., Bufadienolides and other constituents of
Urginea sanguinea. In: PM 63(2): 188-190. 1997.
Mathic C, Ourrison G, (1964) Phytochemistry 3:115, 133, 377
et 379.
Sato, Muro T, Antiviral activity of scillarenin, a plant
bufadienolide. In: Jap J Microbiol 18:441-448. 1974.
Vega FA, (1976) An Rev Acad Farm. 42(1):81.
Further information in:
Frohne D, Pfander HJ. Giftpflanzen - Ein Handbuch fur
Apotheker, Toxikologen und Biologen, 4. Aufl./Wiss. Verlags-
Ges. Stuttgart 1997.
Hansel R, Keller K, Rimpler H, Schneider G (Hrsg.), Hagers
Handbuch der Pharmazeutischen Praxis, 5. Aufl., Bde 4-6
(Drogen): Springer Verlag Berlin, Heidelberg, New York, 1992-
1994.
Joubert JP, Schultz RA Detection of scilliroside in the
preparation of maritime Scille. (Urginea maritima Baker) Ann
Pharm Fr, 42:17-21, 1967 Jan.
Leung AY, Encyclopedia of Common Natural Ingredients Used
in Food, Drugs, Cosmetics, John Wiley & Sons Inc., New York
1980.
Lewin L, Gifte und Vergiftungen, 6. Aufl., Nachdruck, Haug
Verlag, Heidelberg 1992.
Madaus G, Lehrbuch der Biologischen Arzneimittel, Bde 1-3,
Nachdruck, Georg Olms Verlag Hildesheim 1979.
Roth L, Daunderer M, Kormann K, Giftpflanzen, Pflanzengifte,
- Aufl., Ecomed Fachverlag Landsberg Lech 1993.
Schulz R, Hansel R, Rationale Phytotherapie, Springer Verlag
Heidelberg 1996.
Spies T, Praznik W, Hofinger A, Altmann F, Nitsch E, Wutka
R A new bufadienolide from Urginea pancration Planta Med,
235:284-5, Jun, 1992.
Spies T, Praznik W, Hofinger A, Altmann F, Nitsch E, Wutka
R The structure of the fructan sinistrin from Urginea maritima.
Carbohydr Res, 235:221-30, Nov 4, 1992.
Steinegger E, Hansel R, Pharmakognosie, 5. Aufl., Springer
Verlag Heidelberg 1992.
Teuscher E, Lindequist U, Biogene Gifte - Biologie, Chemie,
Pharmakologie, 2. Aufl., Fischer Verlag Stuttgart 1994.
Teuscher E, Biogene Arzneimittel, 5. Aufl., Wiss. Verlagsges.
Stuttgart 1997.
Tuncok Y, Kozan O, Cavdar C, Guven H, Fowler J Estimation
of scilladienolides of Urginea maritima as well as in galenicals
and formulations. Planta Med, 33:213-20, May, 1973.
Tuncok Y, Kozan O, Cavdar C, Guven H, Fowler J Preparation
of the naturally occurring complex of the initial scilladienolides
of Urginea maritima. Planta Med, 33:290-7, May, 1973.